STAT3 and autoimmune hepatitis: Research has demonstrated that exosomes derived from bone marrow MSCs, enriched with miR‐223‐3p, can mitigate autoimmune hepatitis in mice by suppressing STAT3 and phosphorylated STAT3 (p‐STAT3) expression in LPS‐stimulated macrophages [31].